Updated:
GERON CORP
GERON CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000886744, and its reported industry is...
Overview
GERON CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000886744, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-02, it reported net income of USD -83,500,000; total assets of USD 570,540,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- GERON CORP
- Former names in filing history
- GERON CORPORATION (1996-09-12 to 2005-08-05)
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Foster City, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- Nasdaq: GERN
- SEC CIK
- 0000886744
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | — | -$83.5M | $570.5M | $77.6M | -$111.0M | |
| FY2024USD | — | -$174.6M | $593.8M | $79.0M | -$218.6M | |
| FY2023USD | $237,000 | -$184.1M | $394.1M | $70.0M | -$167.7M | |
| FY2022USD | $596,000 | -$141.9M | $190.6M | $56.8M | -$127.4M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research GERON CORP in Altss
Track this company’s investors, transactions and relationships in Altss.